Reference:
- Van Bommel F, Wunsche T, Schurmann D, Berg T. Tenofovir treatment in
patients with lamivudine-resisitant hepatitis B mutants strongly
affects viral replication. Hepatology. 2002; 36:507–508.
- Nelson MR, Katlama C, Montaner JS, et al. The safety of tenofovir
disoproxil fumarate for the treatment of HIV infection in adults: the
first 4 years. AIDS. 2007; 21:1273–1281.
- Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM,
et al. Fanconi syndrome and renal failure induced by tenofovir: A
first case report. Am J Kidney Dis. 2002;40:1331–3
- J. Borrás-Blasco, A.
Navarro-Ruiz, C. Borrás, E.
Casterá. Adverse cutaneous reactions associated with the newest
antiretroviral drugs in patients with human immunodeficiency virus
infection.Journal of Antimicrobial Chemotherapy , Volume 62,
Issue 5, November 2008,879–888
- Staszewiski S, Gallant J, Pozniak AL, Sulieman JMAH, De Jesus E,
Koenig E, et al . Efficacy and safety of tenofovir disoproxil
fumarate (TDF) versus stavudine (d4T) when used in combination with
lamivudine (3TC) and efavirenz (EFV) in HIV-1 infected patients naive
to antiretroviral therapy (ART): 48-week interim
results. In: Program and abstracts of the XIVth International
AIDS Conference . Barcelona, Spain, 7–12 July 2002.
- Calabrese LH, Michel BA, Bloch dA, Arend WP, Edworthy SM, Fauci AS, et
al. The American College of Rheumatology 1990 criteria for the
classification of hypersensitivity vasculitis. Arthritis Rheum 1990
Aug;33(8):1108-1113.
- Sais G, Vidaller A, Jucglà A, Gallardo F, Peyrí J. Colchicine in the
treatment of cutaneous leukocytoclastic vasculitis. Results of a
prospective, randomized controlled trial. Arch dermatol 1995
dec;131(12):1399-1402.
- Said A. Al-Busafi, Abdulatif Al-Suleimani, Aysha Al-Hamadani and Wasif
Rasool Tenofovir-induced Leukocytoclastic Vasculitis. Oman Medical
Journal.2017;32(5):429-431.
- Solay AH, Eser FC, Tutuncu EE, Gencler B, Onder EO. A Leukocytoclastic
Vasculitis Case Due to Tenofovir Use. Journal of Clinical and
Analytical Medicine.2017;8 (suppl 3):187-191.
- WoolleyIJ, VeitchAJ, HarangozoCS, MoyleM, KormanTM. Lichenoid drug
eruption to tenofovir in an HIV/hepatitis B virus co-infected patient.
AIDS. 2004; 18:1857–1858.
- Virath R, Balai M, Gupta LK. Blaschkoid Lichenoid Drug Eruption Due to
Tenofovir. Indian Dermatol Online J . 2020;11(5):826-827.
- Pankaj Jain.A Case of Cutaneous Reaction with Tenofovir Disoproxil
Fumarate. Journal of clinical and experimental hepatology.
2013;3(3):254-255.
- Lockhart SM, Rathbun RC, Stephens JR, Baker DL, Drevets DA, Greenfield
RA, et al. Cutaneous reactions with tenofovir disoproxil fumarate: A
report of nine cases. AIDS. 2007; 21:1370–3
- Obadah Aqtash, Aman Naim Ajmeri, Brent A Thornhill, Elise Anderson and
et. al. A unique case of tenofovir induced DRESS Syndrome associated
with Raynaud’s of the tongue. International Journal of General
Medicine 2019:12 .
- Verma R, Vasudevan B, Shankar S, Pragasam V, Suwal B, Venugopal R.
First reported case of tenofovir-induced photoallergic
reaction. Indian J Pharmacol. 2012; 44:651–3.
- Khanijao Suchit, Kitchloo Karishma, Kamath Anisha, Dancy Leah and et.
al. Tenofovir-induced bullous lesions. Allergy and airway. 2016;150(4)